{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:49:09Z","timestamp":1790725749004,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"am","delay-in-days":276,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004100","name":"Labex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biomaterials.2019.119308","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T05:31:54Z","timestamp":1561527114000},"page":"119308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity"],"prefix":"10.1016","volume":"217","author":[{"given":"Daniel","family":"Sanchez-Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berengere","family":"Villeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Le Borgne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Guyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Kemmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Sallenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Garcia-Verdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2019.119308_bib1","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1016\/j.vaccine.2017.08.034","article-title":"The road to a more effective influenza vaccine: Up to date studies and future prospects","volume":"35","author":"Sano","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/mi.2008.59","article-title":"Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing","volume":"1","author":"Wee","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib3","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1016\/j.vaccine.2017.07.093","article-title":"Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus","volume":"35","author":"Suzuki","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7883\/yoken.JJID.2015.560","article-title":"Intranasal inactivated influenza vaccines: A reasonable approach to improve the efficacy of influenza vaccine?","volume":"69","author":"Tamura","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.biomaterials.2019.119308_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2010.09.013","article-title":"Vaccination strategies to promote mucosal antibody responses","volume":"33","author":"Chen","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2019.119308_bib6","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: Is mucosal tolerance a barrier?","volume":"179","author":"Mestecky","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/21645515.2014.990859","article-title":"ISCOMATRIXTM adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza","volume":"11","author":"Timothy","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.biomaterials.2019.119308_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm","volume":"39","author":"Guo","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib11","first-page":"1","article-title":"Immunology and efficacy of MF59-adjuvanted vaccines","author":"Ko","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.biomaterials.2019.119308_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.smim.2017.09.007","article-title":"Modulating the immune system through nanotechnology","volume":"34","author":"Dacoba","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib13","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1016\/j.vaccine.2009.07.037","article-title":"Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice","volume":"27","author":"Okamoto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151922","article-title":"Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs","volume":"11","author":"Hiremath","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2019.119308_bib15","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.vaccine.2016.08.009","article-title":"Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens","volume":"34","author":"Singh","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2017.09.003","article-title":"Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation","volume":"34","author":"Silva","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib17","doi-asserted-by":"crossref","first-page":"13608","DOI":"10.1021\/jp712087m","article-title":"Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species","volume":"112","author":"Carlson","year":"2008","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.biomaterials.2019.119308_bib18","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1016\/j.biomaterials.2012.06.016","article-title":"Inflammasome formation and IL-1\u03b2 release by human blood monocytes in response to silver nanoparticles","volume":"33","author":"Yang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2019.119308_bib19","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1074\/jbc.M114.610899","article-title":"Silver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasome","volume":"290","author":"Simard","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2019.119308_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3762\/bjnano.4.105","article-title":"Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats","volume":"4","author":"Haberl","year":"2013","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nano7100300","article-title":"Pro-inflammatory versus immunomodulatory effects of silver nanoparticles in the lung: The critical role of dose, size and surface modification","volume":"7","author":"Alessandrini","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biomaterials.2019.119308_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biomaterials.2016.08.018","article-title":"Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection","volume":"106","author":"Chen","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2019.119308_bib23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/acsami.5b08963","article-title":"Spontaneous protein adsorption on graphene oxide nanosheets allowing efficient intracellular vaccine protein delivery","volume":"8","author":"Li","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2019.119308_bib24","doi-asserted-by":"crossref","first-page":"E2191","DOI":"10.1073\/pnas.1302877110","article-title":"GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions","volume":"110","author":"Fejer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biomaterials.2019.119308_bib25","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1038\/cddis.2012.144","article-title":"ATP release and purinergic signaling: A common pathway for particle-mediated inflammasome activation","volume":"3","author":"Riteau","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2019.119308_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1165\/rcmb.2011-0405OC","article-title":"Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway","volume":"47","author":"Barbier","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib27","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acsnano.7b06934","article-title":"Silver nanoparticles impair retinoic acid-inducible gene I-mediated mitochondrial antiviral immunity by blocking the autophagic flux in lung epithelial cells","volume":"12","author":"Villeret","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2019.119308_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12989-014-0078-9","article-title":"Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia","volume":"12","author":"Delaval","year":"2015","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/cvr\/cvt263","article-title":"M1 macrophages act as LT\u03b2R-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis","volume":"101","author":"Guedj","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biomaterials.2019.119308_bib30","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1021\/bi800070u","article-title":"Interaction of surfactant protein A with the intermediate filaments desmin and vimentin","volume":"47","author":"Garcia-Verdugo","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2019.119308_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/bcp.12422","article-title":"Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies","volume":"78","author":"Swaminathan","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2016.00258","article-title":"Inducible bronchus-associated lymphoid tissue: Taming inflammation in the lung","volume":"7","author":"Hwang","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib33","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.1073\/pnas.0700591104","article-title":"Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza","volume":"104","author":"Rangel-Moreno","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biomaterials.2019.119308_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biomaterials.2019.119308_bib35","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/mi.2017.48","article-title":"Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production","volume":"11","author":"Takaki","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib37","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20090410","article-title":"Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice","volume":"206","author":"GeurtsvanKessel","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2019.119308_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm1091","article-title":"Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity","volume":"10","author":"Moyron-Quiroz","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2019.119308_bib39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/eji.1830260226","article-title":"The phenotype and fate of the antibody-forming cells of the splenic foci","volume":"26","author":"Smith","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-3155-9-30","article-title":"Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds","volume":"9","author":"Lara","year":"2011","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.toxlet.2013.02.010","article-title":"Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo","volume":"219","author":"Xu","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biomaterials.2019.119308_bib42","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.2147\/IJN.S109098","article-title":"Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine","volume":"11","author":"Asgary","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2019.119308_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/17435390.2014.958116","article-title":"Persistence of silver nanoparticles in the rat lung: Influence of dose, size, and chemical composition","volume":"9","author":"Anderson","year":"2015","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.biomaterials.2019.119308_bib44","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.vaccine.2008.06.058","article-title":"Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib45","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib46","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.vaccine.2016.08.051","article-title":"An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity","volume":"34","author":"Nakayama","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119308_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7150\/ntno.19796","article-title":"Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation","volume":"1","author":"Chattopadhyay","year":"2017","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.biomaterials.2019.119308_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2006.08.022","article-title":"Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs","volume":"25","author":"Moyron-Quiroz","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2019.119308_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bj.2018.08.003","article-title":"Legacy of the influenza pandemic 1918: The host T cell response","volume":"41","author":"McMichael","year":"2018","journal-title":"Biomed. J."},{"key":"10.1016\/j.biomaterials.2019.119308_bib51","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2019.119308_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/08830185.2013.773326","article-title":"Particulate adjuvant and innate immunity: Past achievements, present findings, and future prospects","volume":"32","author":"Kuroda","year":"2013","journal-title":"Int. Rev. Immunol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219304077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219304077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:48:54Z","timestamp":1758905334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961219304077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":52,"alternative-id":["S0142961219304077"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119308","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119308"}}